liposomal glutathione clinical trials results A Targeted Metabolomic Assessment of Oral Bioavailability and Safety in Humans: A Randomized Crossover Trial Oral supplementation with liposomal glutathione

The observed differential mRNA and protein expression levels of GPX4 and TfR1 in vitro may bear clinical relevance when considering factors such as tumor heterogeneity and the wide-ranging therapeutic response of thyroid tumors harboring diverse mutational signatures

doi: 10.3389/fphar.2020.585163 Received 20 July 2020 Accepted 27 October 2020 Published 30 November 2020 Volume 11 - 2020 Edited by Hua Zhu, The Ohio State University, United States Reviewed by Li Chu, Hebei Medical University, China Yu-Hsun Kao, Taipei Medical University, Taiwan Updates Copyright 2020 Thangaiyan, Arjunan, Govindasamy, Khan, Alhomida and Prasad

The increased activity of TRPV4 channel in the astrocytes of the adult rat hippocampus after cerebral hypoxia/ischemia

Nat Rev Mol Cell Biol 4(7):566577 van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekanne dit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP (2012) Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy